Home » HHS Wants Time to Respond to Purdue Executives’ Suit
HHS Wants Time to Respond to Purdue Executives’ Suit
HHS is asking for more time to respond to
a lawsuit brought by two former Purdue Pharma executives that HHS excluded from participation in federally funded healthcare programs after they pleaded
guilty to misbranding OxyContin. The former executives’ 12-year exclusion from federally funded programs
appears to be the first time exclusion has been imposed based on the “responsible corporate officer” doctrine, which permits plaintiffs to
be charged and convicted due to their status as senior executives, HHS Office of Inspector General spokesman Donald White said.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May